Clinical Trials Directory

Trials / Completed

CompletedNCT04887129

Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

COV-IDD: Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
392 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
3 Years – 72 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to understand how to prevent COVID-19 spread in a school like the Mary Cariola Center (MCC) in Rochester, NY by answering questions like these: how do activities in the school alter chances of infection? Are there people infected with the COVID-19 virus who have no symptoms? How is spread of COVID-19 affected by vaccination rates? Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff safe. Eligible participants are those that work at the Mary Cariola Center (MCC) and interact with the students at MCC who have a high risk of infection from COVID-19. The study lasts for up to 16 months.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCOVID-19 RT-PCR testParticipating individuals (students and employees) will be tested for COVID-19 (RT-PCR) using a specimen collected using a mid-turbinate swab. This asymptomatic testing regime starts on or after (if scheduling testing requires this to begin on a different day) enrollment and is repeated every 5-14 days for up to 16 months . Anyone testing positive is followed up as described below for symptomatic individuals. Those presenting with symptoms will be also tested for COVID-19 (RT-PCR). Those with negative test results will return to the asymptomatic testing protocol. Students who test positive are retested then 3 days until two negative tests. Employees who test positive also be tested every 3 days until two negative tests.
OTHERCOVID-19 Vaccine Education CampaignUtilizing information from focus groups, the investigators will develop and deploy an educational campaign aimed at improving vaccine hesitancy and student health

Timeline

Start date
2021-05-03
Primary completion
2023-08-31
Completion
2024-03-31
First posted
2021-05-14
Last updated
2025-02-03
Results posted
2025-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04887129. Inclusion in this directory is not an endorsement.

Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD) (NCT04887129) · Clinical Trials Directory